Author:
Schanz Julie,Brökers Nils
Publisher
Springer Berlin Heidelberg
Reference17 articles.
1. Alegretti, A. P. u. a. The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia. Revista Brasileira De Hematologia E Hemoterapia 33, 202–206 (2011).
2. Arber, D. A. u. a. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. Blood 128, 462–463 (2016).
3. Bain, B. J. & Béné, M. C. Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia. Acta Haematol-basel 141, 232–244 (2019).
4. Bene, M. C. u. a. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9, 1783–6 (1995).
5. Bene, M. C. u. a. The Reliability and Specificity of c-kit for the Diagnosis of Acute Myeloid Leukemias and Undifferentiated Leukemias. Blood 92, 596–599 (1998).